New from UpToDate

As pharmacy leaders develop health-system pharmacy services, it is important for them to understand successful leadership behaviors and apply them effectively to be successful in managing the challenges of health care. Directors can learn various skills from leaders both in and outside of pharmacy. Learning from these great leaders can provide pharmacy directors with guidance on how to shape various aspects of their leadership style. Winston Churchill is considered to be one of history's greatest leaders; without his leadership, the outcome of World War II may have been completely different. Leadership qualities that made him successful include the use of clear and simple communication, decisiveness, willingness to take risks and learn from failure, commitment to selfimprovement, and the ability to inspire and lead others. This article describes these leadership characteristics displayed by Winston Churchill and discusses ways these qualities can be used effectively by today's pharmacy leaders in building patient-centered services. Publication type: Journal: Article Source: EMBASE 6.Title: Development of an expert professional curriculum for antimicrobial pharmacists in the UK. Citation: The Journal of antimicrobial chemotherapy, May 2015, vol. 70, no. 5, p. 1277-1280 (May 2015) Author(s): Sneddon, Jacqueline, Gilchrist, Mark, Wickens, Hayley Abstract: The role of antimicrobial pharmacists has changed considerably over the past 15 years. We describe here the development and ratification of a new expert professional curriculum to guide the training and development of antimicrobial specialist pharmacists. The curriculum has been developed by the UK Clinical Pharmacy Association Pharmacy Infection Network and endorsed by the Royal Pharmaceutical Society as a tool to support pharmacists in meeting the requirements for joining the Royal Pharmaceutical Society Faculty. This new resource has also been endorsed by PHE, the Scottish Antimicrobial Prescribing Group and the BSAC, and will support antimicrobial pharmacists in delivery of antimicrobial stewardship, which will in turn help the fight against antimicrobial resistance. © The Author 2015. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: [email protected]. Source: Medline 7.Title: Economic evaluation of a randomized controlled trial of pharmacist-supervized patient self-testing of warfarin therapy Citation: Journal of Clinical Pharmacy and Therapeutics, February 2015, vol./is. 40/1(14-19), 0269-4727;1365-2710 (01 Feb 2015) Author(s): Gallagher J., Mc Carthy S., Woods N., Ryan F., O'Shea S., Byrne S. Language: English Abstract: What is known and objective The increase in numbers of patients requiring oral anti-coagulation testing in outpatient clinics has focused attention on alternative flexible systems of anti-coagulation management. One option is pharmacist led patient self-testing (PST) of international normalised ratio (INR) levels. PST has demonstrated improvements in anti-coagulation control, but its cost-effectiveness is inconclusive. This study reports the first costeffectiveness evaluation of a randomized controlled trial of an automated direct-to-patient expert system, enabling remote and effective management of patients on oral anti-coagulation therapy. Methods We conducted an economic evaluation alongside a randomised controlled trial investigating a pharmacist led PST method. The primary outcome was to determine the cost effectiveness of PST in comparison with usual care (management in a hospital based anti-coagulation clinic). Long term anti-coagulation patients were recruited to a 6 month cross over study between PST and routine care in an anti-coagulation clinic. Economic evaluation was from the healthcare payer perspective. Results and discussion On a per patient basis over a 6 month period, PST resulted in an incremental cost of 5908 in comparison with routine care. Patients achieved a significantly higher time in therapeutic range (TTR) during the PST arm in comparison with routine care, (72 +/197% vs. 59 +/135%). Overall cost of managing a patient through pharmacist supervised PST for a 6 month period is 22645. Additional analysis of strategies from a societal perspective indicated that PST was the dominant strategy. What is new and conclusion Pharmacist led patient self-testing is a viable method of management. It provides significant increases in anti-coagulation control for a minimal increase in cost. An economic evaluation of a novel method of pharmacist supervising anticoagulation management. Intervention resulted in a a significant increase in quality of anticoagulation control for a minimal increase in cost. Publication type: Journal: Article